Logo wahanariau.com
  2. Teva pharmaceutical

Teva pharmaceutical

Index
Globenewswire

Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia

Senin, 23 September 2024 - 12:30:00 Wib
Globenewswire

Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia

Sabtu, 21 September 2024 - 16:00:00 Wib
Globenewswire

Teva to Present at the Bank of America 2024 Global Healthcare Conference

Kamis, 12 September 2024 - 06:01:11 Wib
Globenewswire

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Selasa, 27 Agustus 2024 - 05:55:33 Wib
Globenewswire

Teva Announces Strong Growth in Second Quarter Revenues Mainly Driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance

Rabu, 31 Juli 2024 - 18:30:00 Wib